Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Tuaillon, Edouard ^a,b   Mondain, Anne Marie ^b   Nagot, Nicolas ^a,b,c   Ottomani, Laure ^b   Kania, Dramane ^a,d   Nogue, Erika ^c   Rubbo, Pierre Alain ^a,b   Pageaux, Georges Philippe ^e   van de Perre, Philippe ^a,b   Ducos, Jacques ^a,b  

^a UNIV MONTPELLIER   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c Départment de l'Information Médicale   (France)

^d CENTRE MURAZ   (Burkina Faso)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; HEPATITIS B(E) ANTIGEN;

ACCURACY; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ANTIGEN FUNCTION; ANTIGENIC VARIATION; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; MALE; NONHUMAN; QUANTITATIVE ASSAY; REPRODUCIBILITY; VIRUS LOAD; VIRUS REPLICATION; BLOOD; COMPARATIVE STUDY; GENETICS; METHODOLOGY; PHYSIOLOGY;

HEPATITIS B VIRUS;

ADULT; DNA, VIRAL; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; VIRUS REPLICATION;

EID: 84857725097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032143     Document Type: Article

References (31)

1. Marcellin P, Bonino F, Lau GK, Farci P, Yurdaydin C, et al. (2009) Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a. Gastroenterology 136: 2169-2179 e2161-2164.
2. Ryu SH, Chung YH, Choi MH, Kim JA, Shin JW, et al. (2003) Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study. J Hepatol 39: 614-619.
3. Sonneveld MJ, Rijckborst V, Boucher CA, Hansen BE, Janssen HL, (2010) Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline. Hepatology 52: 1251-1257.
4. Marcellin P, Lau GK, Bonino F, Farci P, Hadziyannis S, et al. (2004) Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 351: 1206-1217.
5. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, et al. (2006) Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 131: 1743-1751.
6. Ahn SH, Park YN, Park JY, Chang HY, Lee JM, et al. (2005) Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 42: 188-194.
7. Chen YC, Sheen IS, Chu CM, Liaw YF, (2002) Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 123: 1084-1089.
8. Chu CM, Liaw YF, (2007) HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 45: 1187-1192.
9. Liu J, Yang HI, Lee MH, Lu SN, Jen CL, et al. (2010) Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology 139: 474-482.
10. Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, et al. (2010) Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 51: 1531-1537.
11. Chan HL, Wong VW, Tse AM, Tse CH, Chim AM, et al. (2007) Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol 5: 1462-1468.
12. Chen CH, Lee CM, Wang JH, Tung HD, Hung CH, et al. (2004) Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol 16: 1213-1218.
13. Deguchi M, Yamashita N, Kagita M, Asari S, Iwatani Y, et al. (2004) Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods 115: 217-222.
14. Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, et al. (2006) Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol 37: 206-212.
15. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, et al. (2004) Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126: 1750-1758.
16. Manesis EK, Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, Agelopoulou OP, et al. (2010) Hepatitis B surface antigen: Relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B. J Hepatol.
17. Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, et al. (2010) Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 51: 1933-1944.
18. Borgniet O, Parvaz P, Bouix C, Chevallier P, Trepo C, et al. (2009) Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B. J Med Virol 81: 1336-1342.
19. Brunetto MR, Moriconi F, Bonino F, Lau GK, Farci P, et al. (2009) Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 49: 1141-1150.
20. Moucari R, Mackiewicz V, Lada O, Ripault MP, Castelnau C, et al. (2009) Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatology 49: 1151-1157.
21. Wursthorn K, Jung M, Riva A, Goodman ZD, Lopez P, et al. (2010) Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients. Hepatology 52: 1611-1620.
22. Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, et al. (2010) Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 139: 483-490.
23. Nguyen T, Desmond P, Locarnini S, (2009) The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B. Hepatol Int.
24. Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, et al. (2007) Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 133: 843-852.
25. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, et al. (2001) Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33: 277-286.
26. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, et al. (2010) Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 52: 514-522.
27. van Bommel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, et al. (2010) Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues. Hepatology 51: 73-80.
28. van Bommel F, Wunsche T, Mauss S, Reinke P, Bergk A, et al. (2004) Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology 40: 1421-1425.
29. Sugiyama M, Tanaka Y, Kato T, Orito E, Ito K, et al. (2006) Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44: 915-924.
30. Janssen HL, Kerhof-Los CJ, Heijtink RA, Schalm SW, (1994) Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy. Antiviral Res 23: 251-257.
31. Deguchi M, Yamashita N, Kagita M, Asari S, Iwatani Y, et al. (2004) Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. Journal of virological methods 115: 217-222.